Fink Lab

Whitehead Institute researchers lent their expertise and mentorship to Genes in Space, a challenge that invites students to propose experiments that will be carried out onboard the International Space Station

A standing-room-only audience of faculty and students from Massachusetts Institute of Technology (MIT) offered rapt attention as Whitehead Institute Founding Member and former director Gerald R. Fink delivered MIT’s prestigious Killian Award Lecture

Candida albicans is a human pathogen that causes potentially lethal infections in immunocompromised individuals. Efforts to overcome Candida’s innate resistance to many drugs have been thwarted by an absence of tools enabling genetic modifications. Now, using a modified CRISPR-Cas system, Whitehead Institute researchers can edit the fungus’s genome systematically—an approach that could help scientists understand Candida’s unique biology and identify potential drug targets.